文献速递免疫规划

大肠杆菌生产工艺可产生稳定的登革1型病毒大小颗粒(VSPs)

E. coli production process yields stable dengue 1 virus-sized particles (VSPs).
PubMed 文献 · Vaccine · 2020-03-17

本研究在大肠杆菌中重组表达登革1型E蛋白,经包涵体分离、尿素溶解、固定化金属螯合亲和柱纯化及透析复性获得病毒大小颗粒(VSPs)。颗粒组装经尺寸排阻色谱、动态光散射、透射电镜、原子力显微镜和受激发射损耗荧光显微镜确认,粒径强烈依赖温度、pH、缓冲盐组成和L-精氨酸添加。颗粒在pH 9.5及以上碳酸盐缓冲液中4 °C稳定,短期升温至55 °C不聚集,但结构未达最优病毒样颗粒标准,兔免疫未诱导中和抗体。

要点

  • 大肠杆菌表达的登革1型E蛋白经复性可形成病毒大小颗粒(VSPs),但非最优病毒样颗粒(VLPs)。
  • 颗粒粒径强烈依赖温度、pH、缓冲盐组成和L-精氨酸添加。
  • 颗粒在pH 9.5及以上碳酸盐缓冲液中4 °C稳定,短期升温至55 °C不聚集。

核心结论

  • 所获颗粒未达最优病毒样结构,故命名为「病毒大小颗粒」(VSPs)而非VLPs。
  • 兔免疫VSPs未诱导中和抗体,尽管兔抗体可识别天然病毒。
  • 推测免疫时颗粒构象非最优,因抗免疫原滴度远高于抗热灭活病毒滴度。
  • 目前正研究提高E蛋白VSPs质量以趋向真正VLPs,优化其作为登革疫苗候选的潜力。

研究设计与样本

  • 重组登革1型E蛋白在大肠杆菌中表达,包涵体分离后尿素溶解,经固定化金属螯合亲和柱纯化,透析复性获得VSPs。
  • 颗粒组装经尺寸排阻色谱、动态光散射(DLS)、透射电镜(TEM)、原子力显微镜和受激发射损耗荧光(STED)显微镜确认。
  • 兔免疫实验评估颗粒诱导中和抗体能力。

主要发现

  • 颗粒直径强烈依赖温度、pH、缓冲盐组成和L-精氨酸添加。
  • 颗粒在pH 9.5及以上碳酸盐缓冲液中4 °C稳定,短期升温至55 °C不聚集。
  • 基于DLS、TEM和STED分析,颗粒未达最优病毒样结构,命名为VSPs而非VLPs。
  • 兔免疫VSPs未诱导中和抗体,但兔抗体可识别天然病毒。
  • 抗免疫原滴度远高于抗热灭活病毒滴度,推测免疫时颗粒构象非最优。

局限性

  • 基于DLS、TEM和STED分析,颗粒未达最优病毒样结构。
  • 兔免疫VSPs未诱导中和抗体。
  • 推测免疫时颗粒构象非最优。
  • 目前正研究提高E蛋白VSPs质量以趋向真正VLPs。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dengue fever is one of the most wide-spread vector-borne diseases in the world. Although dengue-associated mortality is low, morbidity and economic impact are high. Current licensed vaccines are limited and mediate only partial protection, thus a cost-effective vaccine with improved efficacy is strongly needed. In this work, recombinant dengue serotype 1 E protein was produced in E. coli, inclusion bodies were isolated and the E protein solubilized in urea and purified using an immobilized metal chelate affinity column. The protein was refolded by dialysis in order to obtain virus-like particles (VLPs). Particle assembly was confirmed using size-exclusion chromatography, dynamic light scattering (DLS), transmission electron microscopy (TEM), atomic force microscopy and stimulated emission depletion fluorescence (STED) microscopy. Particle diameter was strongly dependent on temperature, pH, buffer salt composition, and addition of L-arginine. Particles were stable in carbonate buffer at pH 9.5 and higher at 4 °C and did not aggregate during short-term temperature increase up to 55 °C. However, on basis of the above analyses, especially the results of DLS, TEM and STED, it was concluded that the particles obtained did not have an optimal virus-like structure and were therefore designated "virus-sized particles" (VSPs) rather than VLPs. Immunization of rabbits with the particles did not induce neutralizing antibodies, despite the recognition of the native virus by rabbit antibodies. As the titers against the immunogen were much higher than against the (heat-inactivated) virus, it is assumed that the conformation of the particles at the time of immunization was not optimal. Studies are currently underway to improve the quality of the E protein virus-sized particles towards true virus-like particles in order to optimize its potential as a dengue vaccine candidate.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hirsch J, Faber BW, Crowe JE, et al. E. coli production process yields stable dengue 1 virus-sized particles (VSPs). Vaccine. 2020. PMID: 32197924. doi:10.1016/j.vaccine.2020.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。